1. HOME
  2. Drug List

Drug List

Axitinib

Information
Axitinib is a multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ and c-Kit with IC50 of 0.1 nM, 0.2 nM, 0.1-0.3 nM, 1.6 nM and 1.7 nM, respectively.
Target
c-Kit,PDGFR,VEGFR
Pathway
Protein Tyrosine Kinase
Formula
C22H18N4OS
CAS Number
319460-85-0
SMILES
CNC(=O)C1=CC=CC=C1SC1=CC2=C(C=C1)C(\C=C\C1=CC=CC=N1)=NN2 |c:6,8,14,16,24,26,28,t:4,12,22|

Bosutinib (SKI-606)

Information
Bosutinib (SKI-606) is a novel, dual Src/Abl inhibitor with IC50 of 1.2 nM and 1 nM, respectively.
Target
Src
Pathway
Angiogenesis
Formula
C26H29Cl2N5O3
CAS Number
380843-75-4
SMILES
COC1=C(Cl)C=C(Cl)C(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C1 |c:2,12,37,t:5,10,14,28,32|

PD0325901

Information
PD0325901 (PD325901) is selective and non ATP-competitive MEK inhibitor with IC50 of 0.33 nM, roughly 500-fold more potent than CI-1040 on phosphorylation of ERK1 and ERK2. Phase 1/2.
Target
MEK
Pathway
DNA Damage
Formula
C16H14F3IN2O4
CAS Number
391210-10-9
SMILES
OC[C@@H](O)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1 |r,c:9,17,25,t:12,14,22|

Rapamycin (Sirolimus)

Information
Rapamycin (Sirolimus, AY-22989, WY-090217) is a specific mTOR inhibitor with IC50 of ~0.1 nM.
Target
Autophagy,mTOR
Pathway
DNA Damage
Formula
C51H79NO13
CAS Number
53123-88-9
SMILES
CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1O |r,c:14,33,t:29,31|

Sunitinib Malate

Information
Sunitinib Malate is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80 nM and 2 nM, and also inhibits c-Kit.
Target
c-Kit,PDGFR,VEGFR
Pathway
Microbiology
Formula
C26H33FN4O7
CAS Number
341031-54-7
SMILES
O[C@@H](CC(O)=O)C(O)=O.CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=CC=C(F)C=C23)=C1C |r,c:18,36,t:28,30,33|

Temsirolimus (CCI-779, NSC 683864)

Information
Temsirolimus (CCI-779) is a specific mTOR inhibitor with IC50 of 1.76 μM.
Target
mTOR
Pathway
Neuronal Signaling
Formula
C56H87NO16
CAS Number
162635-04-3
SMILES
CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OC(=O)C(C)(CO)CO |r,c:14,33,t:29,31|

Crizotinib (PF-02341066)

Information
PF-2341066 (Crizotinib) is a potent inhibitor of c-Met and ALK with IC50 of 11 nM and 24 nM, respectivley.
Target
ALK,c-Met
Pathway
Others
Formula
C21H22Cl2FN5O
CAS Number
877399-52-5, 877399-53-6 (acetate)
SMILES
C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl |r,c:3,6,8,14,24,27,30,t:11|

SU11274

Information
SU11274 is a selective Met inhibitor with IC50 of 10 nM, no effects on PGDFRβ, EGFR or Tie2.
Target
c-Met
Pathway
Neuronal Signaling
Formula
C28H30ClN5O4S
CAS Number
658084-23-2
SMILES
CN(C1=CC(Cl)=CC=C1)S(=O)(=O)C1=CC2=C(NC(=O)\C2=C/C2=C(C)C(C(=O)N3CCN(C)CC3)=C(C)N2)C=C1 |c:5,7,23,41,t:2,13,15,36|

PF-04217903

Information
PF-04217903 is a selective ATP-competitive c-Met inhibitor with IC50 of 4.8 nM, susceptible to oncogenic mutations (no activity to Y1230C mutant). Phase 1.
Target
c-Met
Pathway
Others
Formula
C19H16N8O
CAS Number
956905-27-4
SMILES
OCCN1C=C(C=N1)C1=NC2=C(N=NN2CC2=CC3=CC=CN=C3C=C2)N=C1 |c:4,6,13,22,24,27,30,t:9,11,18,20|

Palbociclib (PD-0332991) HCl

Information
PD0332991 is a highly selective inhibitor of CDK4/6 with IC50 of 11 nM/16 nM. It shows no activity against CDK1/2/5, EGFR, FGFR, PDGFR, InsR, etc. Phase 2/3.
Target
CDK
Pathway
Others
Formula
C24H30ClN7O2
CAS Number
827022-32-2, 571190-30-2 (free base)
SMILES
Cl.CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O |c:3,13,15,25,t:6,8,11|

CP-724714

Information
CP-724,714 is a potent, selective inhibitor of HER2/ErbB2 with IC50 of 10 nM, >640-fold selectivity against EGFR, InsR, IRG-1R, PDGFR, VEGFR2, Abl, Src, c-Met etc. Phase 2.
Target
EGFR,HER2
Pathway
Protein Tyrosine Kinase
Formula
C27H27N5O3
CAS Number
537705-08-1
SMILES
COCC(=O)NC\C=C\C1=CC=C2N=CN=C(NC3=CC=C(OC4=CC=C(C)N=C4)C(C)=C3)C2=C1 |c:13,28,32,36,t:9,11,15,18,20,23,25|

PD98059

Information
PD98059 is a non-ATP competitive MEK inhibitor with IC50 of 2 μM, specifically inhibits MEK-1-mediated activation of MAPK; does not directly inhibit ERK1 or ERK2.
Target
MEK
Pathway
MAPK
Formula
C16H13NO3
CAS Number
167869-21-8
SMILES
COC1=C(N)C(=CC=C1)C1=CC(=O)C2=CC=CC=C2O1 |c:2,5,7,16,18,t:10,14|

Exemestane

Information
Exemestane is an aromatase inhibitor, inhibits human placental and rat ovarian aromatase with IC50 of 30 nM and 40 nM, respectively.
Target
Aromatase
Pathway
Endocrinology & Hormones
Formula
C20H24O2
CAS Number
107868-30-4
SMILES
[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC(=C)C2=CC(=O)C=C[C@]12C |r,c:23,t:19|

Irinotecan

Information
Irinotecan is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively.
Target
Topoisomerase
Pathway
DNA Damage
Formula
C33H38N4O6
CAS Number
97682-44-5
SMILES
CCC1=C2C=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=CC2=NC2=C1CN1C2=CC2=C(COC(=O)[C@]2(O)CC)C1=O |r,c:2,23,26,28,t:4,34,36|

Cladribine

Information
Cladribine is an adenosine deaminase inhibitor for U266, RPMI8226, and MM1.S cells with IC50 of approximately 2.43 μM, 0.75 μM, and 0.18 μM, respectively.
Target
DNA/RNA Synthesis
Pathway
DNA Damage
Formula
C10H12ClN5O3
CAS Number
4291-63-8
SMILES
NC1=NC(Cl)=NC2=C1N=CN2[C@H]1C[C@H](O)[C@@H](CO)O1 |r,c:4,6,9,t:1|

Doxorubicin (Adriamycin) HCl

Information
Doxorubicin (Adriamycin) is an antibiotic agent that inhibits DNA topoisomerase II and induces DNA damage and apoptosis.
Target
Autophagy,Topoisomerase
Pathway
DNA Damage
Formula
C27H30ClNO11
CAS Number
25316-40-9
SMILES
Cl.[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(=O)C4=C(OC)C=CC=C4C3=O)C(O)=C12)C(=O)CO |r,c:17,24,28,30,t:20,37|

PFI-1 (PF-6405761)

Information
PFI-1 is a selective BET (bromodomain-containing protein) inhibitor for BRD4 with IC50 of 0.22 μM.
Target
Epigenetic Reader Domain
Pathway
Epigenetics
Formula
C16H17N3O4S
CAS Number
1403764-72-6
SMILES
COC1=C(C=CC=C1)S(=O)(=O)NC1=CC=C2NC(=O)N(C)CC2=C1 |c:4,6,24,t:2,13,15|

Letrozole

Information
Letrozole is a third generation inhibitor of aromatase with IC50 of 0.07-20 nM.
Target
Aromatase
Pathway
Endocrinology & Hormones
Formula
C17H11N5
CAS Number
112809-51-5
SMILES
N#CC1=CC=C(C=C1)C(N1C=NC=N1)C1=CC=C(C=C1)C#N |c:4,6,11,13,18,20,t:2,16|

Celecoxib

Information
Celecoxib is a selective COX-2 inhibitor with IC50 of 40 nM.
Target
COX
Pathway
Neuronal Signaling
Formula
C17H14F3N3O2S
CAS Number
169590-42-5
SMILES
CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F |c:3,5,10,16,18,t:1,8,14|

PD173074

Information
PD173074 is a potent FGFR1 inhibitor with IC50 of ~25 nM and also inhibits VEGFR2 with IC50 of 100-200 nM, ~1000-fold selective for FGFR1 than PDGFR and c-Src.
Target
FGFR,VEGFR
Pathway
Angiogenesis
Formula
C28H41N7O3
CAS Number
219580-11-7
SMILES
CCN(CC)CCCCNC1=NC=C2C=C(C(NC(=O)NC(C)(C)C)=NC2=N1)C1=CC(OC)=CC(OC)=C1 |c:14,24,27,34,38,t:10,12,30|

Asenapine maleate

Information
Asenapine inhibits adrenergic receptor (α1, α2A, α2B, α2C) with Ki of 0.25-1.2 nM and also inhibits 5-HT receptor (1A, 1B, 2A, 2B, 2C, 5A, 6, 7) with Ki of 0.03-4.0 nM.
Target
5-HT Receptor,Adrenergic Receptor
Pathway
Neuronal Signaling
Formula
C21H20ClNO5
CAS Number
65576-45-6, 135883-08-8 (Maleic acid)
SMILES
OC(=O)\C=C/C(O)=O.[H][C@]12CN(C)C[C@]1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1 |r,c:16,19,22,24,27,30|

Benazepril HCl

Information
Benazepril is a medication used to treat high blood pressure.
Target
RAAS
Pathway
Endocrinology & Hormones
Formula
C24H29ClN2O5
CAS Number
86541-74-4
SMILES
Cl.CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]1CCC2=C(C=CC=C2)N(CC(O)=O)C1=O |r,c:10,12,21,23,t:8,19|

Cetirizine DiHCl

Information
Cetirizine DiHCl is an antihistamine.
Target
Histamine Receptor
Pathway
Neuronal Signaling
Formula
C21H27Cl3N2O3
CAS Number
83881-52-1
SMILES
Cl.Cl.OC(=O)COCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1 |c:17,19,27,t:15,22,24|

Cilostazol

Information
Cilostazol is a potent cyclic nucleotide phosphodiesterase type 3 (PDE3) inhibitor with IC50 of 0.2 μM and inhibitor of adenosine uptake.
Target
PDE
Pathway
Metabolism
Formula
C20H27N5O2
CAS Number
73963-72-1
SMILES
O=C1CCC2=C(N1)C=CC(OCCCCC1=NN=NN1C1CCCCC1)=C2 |c:4,8,18,28,t:16|

Doxazosin Mesylate

Information
Doxazosin mesylate is an alpha-1 adrenergic receptor blocker.
Target
Adrenergic Receptor
Pathway
Neuronal Signaling
Formula
C24H29N5O8S
CAS Number
77883-43-3
SMILES
CS(O)(=O)=O.COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1COC2=C(O1)C=CC=C2 |c:6,13,15,18,33,37,39,t:10|

Etodolac

Information
Etodolac (Lodine) is a COX inhibitor with an IC50 of 53.5 nM.
Target
COX
Pathway
Neuronal Signaling
Formula
C17H21NO3
CAS Number
41340-25-4
SMILES
CCC1=CC=CC2=C1NC1=C2CCO[C@]1(CC)CC(O)=O |r,c:4,6,10,t:2|

Fluconazole

Information
Fluconazole is a triazole antifungal drug used in the treatment and prevention of superficial and systemic fungal infections.
Target
P450 (e.g. CYP17)
Pathway
Others
Formula
C13H12F2N6O
CAS Number
86386-73-4
SMILES
OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1 |c:4,6,11,13,16,22,t:19|

Gabapentin HCl

Information
Gabapentin HCl is a GABA analogue, used to treat seizures and neuropathic pain.
Target
GABA Receptor
Pathway
Neuronal Signaling
Formula
C9H18ClNO2
CAS Number
60142-95-2
SMILES
Cl.NCC1(CC(O)=O)CCCCC1

Lansoprazole

Information
Lansoprazole is a proton-pump inhibitor (PPI) which prevents the stomach from producing gastric acid.
Target
Proton Pump
Pathway
Transmembrane Transporters
Formula
C16H14F3N3O2S
CAS Number
103577-45-3
SMILES
CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1 |c:1,9,11,21,23,t:17,19|

Tigecycline

Information
Tigecycline is bacteriostatic and is a protein synthesis inhibitor by binding to the 30S ribosomal subunit of bacteria and thereby blocking entry of Aminoacyl-tRNA into the A site of the ribosome during prokaryotic translation.
Target
Antifection
Pathway
Others
Formula
C29H39N5O8
CAS Number
220620-09-7
SMILES
[H][C@@]12CC3=C(C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)C(O)=C(NC(=O)CNC(C)(C)C)C=C3N(C)C |r,c:3,42,t:8,18,31|

Linezolid

Information
Linezolid is a synthetic antibiotic used for the treatment of serious infections.
Target
Antifection
Pathway
Others
Formula
C16H20FN3O4
CAS Number
165800-03-3
SMILES
CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(N2CCOCC2)C(F)=C1 |r,c:24,t:12,14|

Sildenafil Citrate

Information
Sildenafil, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5), is a well-tolerated and highly effective treatment for erectile dysfunction.
Target
PDE
Pathway
Metabolism
Formula
C28H38N6O11S
CAS Number
171599-83-0
SMILES
OC(=O)CC(O)(CC(O)=O)C(O)=O.CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1 |c:19,22,30,32,t:15,28|

Varenicline Tartrate

Information
Varenicline Tartrate is a nicotinic AChR partial agonist, used to treat nicotine addiction.
Target
AChR
Pathway
Neuronal Signaling
Formula
C17H19N3O6
CAS Number
375815-87-5
SMILES
O[C@H]([C@@H](O)C(O)=O)C(O)=O.C1C2CNCC1C1=C2C=C2N=CC=NC2=C1 |r,c:16,21,23,26,t:19|

Venlafaxine HCl

Information
Venlafaxine is an arylalkanolamine serotonin-norepinephrine reuptake inhibitor (SNRI).
Target
5-HT Receptor
Pathway
Neuronal Signaling
Formula
C17H28ClNO2
CAS Number
99300-78-4
SMILES
Cl.COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1 |c:4,6,t:2|

Voriconazole

Information
Voriconazole is a new triazole derivative similar to fluconazole and itraconazole that acts by inhibiting fungal cytochrome P-450-dependent, 14-alpha-sterol demethylase-mediated synthesis of ergosterol.
Target
P450 (e.g. CYP17)
Pathway
Metabolism
Formula
C16H14F3N5O
CAS Number
137234-62-9
SMILES
C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=CC=C(F)C=C1F |r,c:4,6,14,16,24,t:2,19,21|

Ziprasidone HCl

Information
Ziprasidone HCl was the fifth atypical antipsychotic.
Target
5-HT Receptor,Dopamine Receptor
Pathway
Others
Formula
C21H22Cl2N4OS
CAS Number
122883-93-6
SMILES
Cl.ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2 |c:10,25,28,30,t:1,3,22|

Orantinib (TSU-68, SU6668)

Information
SU6668 has greatest potency against PDGFR autophosphorylation with Ki of 8 nM, but also strongly inhibits Flk-1 and FGFR1 trans-phosphorylation, little activity against IGF-1R, Met, Src, Lck, Zap70, Abl and CDK2; does not inhibit EGFR. Phase 3.
Target
FGFR,PDGFR,VEGFR
Pathway
Protein Tyrosine Kinase
Formula
C18H18N2O3
CAS Number
252916-29-3
SMILES
CC1=C(CCC(O)=O)C(C)=C(N1)\C=C1/C(=O)NC2=CC=CC=C12 |c:1,9,20,t:18,22|

Alprostadil

Information
Alprostadil is used as a drug in the treatment of erectile dysfunction and has vasodilatory properties.
Target
Immunology & Inflammation related
Pathway
Others
Formula
C20H34O5
CAS Number
745-65-3
SMILES
CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O |r|

CP-673451

Information
CP 673451 is a selective inhibitor of PDGFRα/β with IC50 of 10 nM/1 nM, exhibits >450-fold selectivity over other angiogenic receptors, has antiangiogenic and antitumor activity.
Target
PDGFR
Pathway
Protein Tyrosine Kinase
Formula
C24H27N5O2
CAS Number
343787-29-1
SMILES
COCCOC1=CC=C2N(C=NC2=C1)C1=NC2=C(C=CC=C2C=C1)N1CCC(N)CC1 |c:10,13,20,22,25,t:5,7,16,18|

PD318088

Information
PD318088 is a non-ATP competitive allosteric MEK1/2 inhibitor, binds simultaneously with ATP in a region of the MEK1 active site that is adjacent to the ATP-binding site.
Target
MEK
Pathway
MAPK
Formula
C16H13BrF3IN2O4
CAS Number
391210-00-7
SMILES
OCC(O)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C(Br)=C1 |c:9,17,26,t:12,14,22|

Sulfasalazine

Information
Sulfasalazine is a sulfa agent and a derivative of mesalazine used primarily as an anti-inflammatory agent.
Target
COX,NF-κB
Pathway
Others
Formula
C18H14N4O5S
CAS Number
599-79-1
SMILES
OC(=O)C1=C(O)C=CC(=C1)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1 |c:3,6,8,15,17,26,28,t:13,24|

Palbociclib (PD0332991) Isethionate

Information
Palbociclib (PD0332991) Isethionate is a highly selective inhibitor of CDK4/6 with IC50 of 11 nM/16 nM in cell-free assays. It shows no activity against CDK1/2/5, EGFR, FGFR, PDGFR, InsR, etc. Phase 3.
Target
CDK
Pathway
Cell Cycle
Formula
C26H35N7O6S
CAS Number
827022-33-3
SMILES
OCCS(O)(=O)=O.CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O |c:9,19,21,31,t:12,14,17|

Apixaban

Information
Apixaban is a highly selective, reversible inhibitor of Factor Xa with Ki of 0.08 nM and 0.17 nM in human and rabbit, respectively.
Target
Factor Xa
Pathway
Metabolism
Formula
C25H25N5O4
CAS Number
503612-47-3
SMILES
COC1=CC=C(C=C1)N1N=C(C(N)=O)C2=C1C(=O)N(CC2)C1=CC=C(C=C1)N1CCCCC1=O |c:4,6,15,26,28,t:2,10,24|

Cefoperazone

Information
Cefoperazone is a cephalosporin antibiotic for inhibition of rMrp2-mediated [3H]E217βG uptake with IC50 of 199 μM.
Target
Antifection
Pathway
Others
Formula
C25H27N9O8S2
CAS Number
62893-19-0
SMILES
[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@H]2NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)C1=CC=C(O)C=C1)C(O)=O |r,c:9,13,44,t:7,39,41|

Ketoprofen

Information
Ketoprofen (Actron) is a non-selective NSAID with IC50 of 0.5 μM and 2.33 μM for human recombinant COX-1 and COX-2, respectively.
Target
COX
Pathway
Neuronal Signaling
Formula
C16H14O3
CAS Number
22071-15-4
SMILES
CC(C(O)=O)C1=CC(=CC=C1)C(=O)C1=CC=CC=C1 |c:7,9,16,18,t:5,14|

Dofetilide

Information
Dofetilide(Tikosyn) is a class III antiarrhythmic agent.
Target
Potassium Channel
Pathway
Others
Formula
C19H27N3O5S2
CAS Number
115256-11-6
SMILES
CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1 |c:14,28,t:5,7,19,21|

Glipizide

Information
Glipizide(Glucotrol) is used to treat high blood sugar levels caused by a type of diabetes mellitus called type 2 diabetes.
Target
Others
Pathway
Others
Formula
C21H27N5O4S
CAS Number
29094-61-9
SMILES
CC1=NC=C(N=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1 |c:3,5,15,17,t:1,13|

Glyburide (Glibenclamide)

Information
Glyburide (Diabeta) is an anti-diabetic compound in a class of medications known as sulfonylureas, closely related to sulfa agents.
Target
Potassium Channel
Pathway
Others
Formula
C23H28ClN3O5S
CAS Number
10238-21-8
SMILES
COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1 |c:7,17,19,t:2,4,15|

Levonorgestrel

Information
Levonorgestrel(Levonelle) is a synthetic progestogen used as an active ingredient in some hormonal contraceptives.
Target
Estrogen/progestogen Receptor
Pathway
Others
Formula
C21H28O2
CAS Number
797-63-7
SMILES
[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H] |r,c:22|

Gemfibrozil

Information
Gemfibrozil (Lopid) is a compound used to lower lipid levels.
Target
PPAR
Pathway
Others
Formula
C15H22O3
CAS Number
25812-30-0
SMILES
CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1 |c:16,t:1,13|

Methylprednisolone

Information
Methylprednisolone is a synthetic corticosteroid with anti-inflammatory and immunomodulating properties.
Target
Glucocorticoid Receptor
Pathway
Others
Formula
C22H30O5
CAS Number
83-43-2
SMILES
[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C |r,c:28,t:24|

Ramipril

Information
Ramipril is an angiotensin-converting enzyme (ACE) inhibitor with IC50 of 5 nM.
Target
RAAS
Pathway
Endocrinology & Hormones
Formula
C23H32N2O5
CAS Number
87333-19-5
SMILES
CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1[C@H]2CCC[C@H]2C[C@H]1C(O)=O |r,c:10,12,t:8|

Nifedipine

Information
Nifedipine(Adalat), a potent vasodilator agent with calcium antagonistic action.
Target
Calcium Channel
Pathway
Others
Formula
C17H18N2O6
CAS Number
21829-25-4
SMILES
COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC |c:4,9,15,17,t:13|

Amlodipine

Information
Amlodipine(Norvasc) is a long-acting calcium channel blocker with an IC50 of 1.9 nM.
Target
Calcium Channel
Pathway
Transmembrane Transporters
Formula
C20H25ClN2O5
CAS Number
88150-42-9
SMILES
CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=C(Cl)C=CC=C1)C(=O)OC |c:5,14,18,21,23|

Sulbactam

Information
Sulbactam is a beta-lactamase inhibitor with an average IC50 of 0.8 μM.
Target
Antifection
Pathway
Others
Formula
C8H11NO5S
CAS Number
68373-14-8
SMILES
[H][C@@]12CC(=O)N1[C@@]([H])(C(O)=O)C(C)(C)S2(=O)=O |r|

Amiodarone HCl

Information
Amiodarone HCl is an antiarrhythmic drug for inhibition of ATP-sensitive potassium channel with IC50 of 19.1 μM.
Target
Autophagy,Potassium Channel
Pathway
Transmembrane Transporters
Formula
C25H30ClI2NO3
CAS Number
19774-82-4
SMILES
Cl.CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2 |c:4,22,25,29,31,t:8,11|

Maraviroc

Information
Maraviroc is a CCR5 antagonist for MIP-1α, MIP-1β and RANTES with IC50 of 3.3 nM, 7.2 nM and 5.2 nM, respectively.
Target
CCR
Pathway
Microbiology
Formula
C29H41F2N5O
CAS Number
376348-65-1
SMILES
CC(C)C1=NN=C(C)N1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)C1=CC=CC=C1 |r,c:37,39,t:3,5,35|

Clindamycin Phosphate

Information
Clindamycin Phosphate is a lincosamide antibiotic for Plasmodium falciparum with IC50 of 12 nM.
Target
Antifection
Pathway
Others
Formula
C18H34ClN2O8PS
CAS Number
24729-96-2
SMILES
CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]1O[C@H](SC)[C@H](OP(O)(O)=O)[C@@H](O)[C@H]1O |r|

Atorvastatin Calcium

Information
Atorvastatin (Lipitor) is an inhibitor of HMG-CoA reductase used as a cholesterol-lowering medication that blocks the production of cholesterol.
Target
HMG-CoA Reductase
Pathway
Metabolism
Formula
C66H68CaF2N4O10
CAS Number
134523-03-8
SMILES
[Ca++].CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(=C(N1CC[C@@H](O)C[C@@H](O)CC([O-])=O)C1=CC=C(F)C=C1)C1=CC=CC=C1.CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(=C(N1CC[C@@H](O)C[C@@H](O)CC([O-])=O)C1=CC=C(F)C=C1)C1=CC=CC=C1 |r,c:3,10,12,15,35,40,42,47,54,56,59,79,84,86,t:8,30,32,38,52,74,76,82|

Betaxolol

Information
Betaxolol is a selective beta1 adrenergic receptor blocker used in the treatment of hypertension and glaucoma.
Target
Adrenergic Receptor
Pathway
Neuronal Signaling
Formula
C18H29NO3
CAS Number
659-18-7
SMILES
CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1 |c:21,t:9,11|

Ibutilide Fumarate

Information
Ibutilide Fumarate is a Class III antiarrhythmic agent that is indicated for acute cardioconversion of atrial fibrillation and atrial flutter of a recent onset to sinus rhythm by induction of slow inward sodium current, which prolongs action potential and refractory period of myocardial cells.
Target
Sodium Channel
Pathway
Transmembrane Transporters
Formula
C44H76N4O10S2
CAS Number
122647-32-9
SMILES
OC(=O)\C=C\C(O)=O.CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1.CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1 |c:31,57,t:22,24,48,50|

Bazedoxifene HCl

Information
Bazedoxifene HCl is a novel, non-steroidal, indole-based estrogen receptor modulator (SERM) binding to both ERα and ERβ with IC50 of 23 nM and 89 nM.
Target
Estrogen/progestogen Receptor
Pathway
Endocrinology & Hormones
Formula
C30H35ClN2O3
CAS Number
198480-56-7
SMILES
Cl.CC1=C(N(CC2=CC=C(OCCN3CCCCCC3)C=C2)C2=CC=C(O)C=C12)C1=CC=C(O)C=C1 |c:20,37,t:1,5,7,23,25,28,32,34|

Gabapentin

Information
Gabapentin is a GABA analogue, used to treat seizures and neuropathic pain.
Target
GABA Receptor
Pathway
Neuronal Signaling
Formula
C9H17NO2
CAS Number
60142-96-3
SMILES
NCC1(CC(O)=O)CCCCC1

PF-4708671

Information
PF-4708671 is a cell-permeable inhibitor of p70 ribosomal S6 kinase (S6K1 isoform) with Ki/IC50 of 20 nM/160 nM, 400-fold greater selectivity for S6K1 than S6K2, and 4- and >20-fold selectivity for S6K1 than MSK1 and RSK1/2, respectively. First S6K1-specific inhibitor to be reported.
Target
S6 Kinase
Pathway
PI3K/Akt/mTOR
Formula
C19H21F3N6
CAS Number
1255517-76-0
SMILES
CCC1=CN=CN=C1N1CCN(CC2=NC3=C(N2)C=CC(=C3)C(F)(F)F)CC1 |c:4,6,16,20,22,t:2,14|

Bazedoxifene Acetate

Information
Bazedoxifene Acetate is a third generation selective estrogen receptor modulator (SERM).
Target
Estrogen/progestogen Receptor
Pathway
Endocrinology & Hormones
Formula
C32H38N2O5
CAS Number
198481-33-3
SMILES
CC(O)=O.CC1=C(N(CC2=CC=C(OCCN3CCCCCC3)C=C2)C2=CC=C(O)C=C12)C1=CC=C(O)C=C1 |c:23,40,t:4,8,10,26,28,31,35,37|

PD128907 HCl

Information
PD 128907 HCl is a potent and selective dopamine D3 receptor agonist, with EC50 of 0.64 nM, exhibits 53-fold selectivity over dopamine D2 receptor.
Target
Dopamine Receptor
Pathway
Neuronal Signaling
Formula
C14H20ClNO3
CAS Number
112960-16-4
SMILES
Cl.[H][C@]12COC3=CC=C(O)C=C3[C@]1([H])OCCN2CCC |r,c:9,t:4,6|

PF-3716556

Information
PF 3716556 is a potent and selective P-CAB (potassium-competitive acid blocker), with pIC50 of 6.026 and 7.095 for the inhibition of porcine H+,K+-ATPase activity in ion-leaky and ion-tight assay, respectively, inhibits gastric acid secretion, displays no activity at Na+,K+-ATPase, used for the treatment of gastroesophageal reflux disease.
Target
ATPase,Proton Pump
Pathway
Transmembrane Transporters
Formula
C22H26N4O3
CAS Number
928774-43-0
SMILES
CN(CCO)C(=O)C1=CN2C=C(C)N=C2C(N[C@@H]2CCOC3=CC=CC(C)=C23)=C1 |r,c:13,24,30,t:7,10,22,27|

UK 383367

Information
UK-383367 is a procollagen C-proteinase inhibitor with IC50 of 44 nM, has excellent selectivity over MMPs.
Target
Procollagen C Proteinase
Pathway
Metabolism
Formula
C15H24N4O4
CAS Number
348622-88-8
SMILES
NC(=O)C1=NOC(=N1)[C@H](CCCC1CCCCC1)CC(=O)NO |r,c:6,t:3|

Clindamycin HCl

Information
Clindamycin hydrochloride(Dalacin) is the hydrated hydrochloride salt of clindamycin which is a semisynthetic antibiotic.
Target
Antifection
Pathway
Others
Formula
C18H34Cl2N2O5S
CAS Number
21462-39-5
SMILES
Cl.CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H](C(C)Cl)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O |r|

Phenytoin

Information
Phenytoin is an inactive voltage-gated sodium channel stabilizer.
Target
Sodium Channel
Pathway
Transmembrane Transporters
Formula
C15H12N2O2
CAS Number
57-41-0
SMILES
O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1 |c:10,12,17,19,t:8,15|

Tiotropium Bromide hydrate

Information
Tiotropium Bromide hydrate is a monohydrate of tiotropium bromide (Spiriva; Tiova; BA 679BR; tiopropium) that is an anticholinergic and bronchodilator and a muscarinic receptor antagonist.
Target
AChR
Pathway
Neuronal Signaling
Formula
C19H24BrNO5S2
CAS Number
139404-48-1
SMILES
O.[Br-].[H][C@]12C[C@@H](C[C@]([H])([C@H]3O[C@@H]13)[N+]2(C)C)OC(=O)C(O)(C1=CC=CS1)C1=CC=CS1 |r,c:23,29,t:21,27|

Tolterodine tartrate

Information
Tolterodine tartrate (Detrol LA) is a tartrate salt of tolterodine that is a competitive muscarinic receptor antagonist.
Target
AChR
Pathway
Neuronal Signaling
Formula
C26H37NO7
CAS Number
124937-52-6
SMILES
O[C@H]([C@@H](O)C(O)=O)C(O)=O.CC(C)N(CC[C@H](C1=CC=CC=C1)C1=CC(C)=CC=C1O)C(C)C |r,c:18,20,26,28,t:16,23|

Sulbactam sodium

Information
Sulbactam sodium (Unasyn) is an irreversible β-lactamase inhibitor.
Target
Antifection
Pathway
Others
Formula
C8H10NNaO5S
CAS Number
69388-84-7
SMILES
[Na+].[H][C@@]12CC(=O)N1[C@@]([H])(C([O-])=O)C(C)(C)S2(=O)=O |r|

Medroxyprogesterone acetate

Information
Medroxyprogesterone acetate is a progestin, a synthetic variant of the human hormone progesterone and a potent progesterone receptor agonist.
Target
Estrogen/progestogen Receptor
Pathway
Endocrinology & Hormones
Formula
C24H34O4
CAS Number
71-58-9
SMILES
[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C |r,t:25|

Quinapril HCl

Information
Quinapril hydrochloride (Accupril) is the hydrochloride salt of quinapril that is an angiotensin-converting enzyme inhibitor with a Ki of 20 μM.
Target
RAAS
Pathway
Endocrinology & Hormones
Formula
C25H31ClN2O5
CAS Number
82586-55-8
SMILES
Cl.CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=C(C[C@H]1C(O)=O)C=CC=C2 |r,c:10,12,22,30,32,t:8|

Miglitol

Information
Miglitol is an oral anti-diabetic drug.
Target
Others
Pathway
Others
Formula
C8H17NO5
CAS Number
72432-03-2
SMILES
OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO |r|

Pioglitazone

Information
Pioglitazone (Actos) is a selective peroxisome proliferator-activated receptor gamma stimulator.
Target
PPAR
Pathway
Others
Formula
C19H20N2O3S
CAS Number
111025-46-8
SMILES
CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C1 |c:22,25,t:2,4,9,11|

Clindamycin palmitate HCl

Information
Clindamycin palmitate HCl is a water soluble hydrochloride salt of the ester of clindamycin and palmitic acid and a lincosamide antibiotic.
Target
Others
Pathway
Others
Formula
C34H64Cl2N2O6S
CAS Number
25507-04-4
SMILES
Cl.CCCCCCCCCCCCCCCC(=O)OC1C(O)C(O)C(OC1SC)C(NC(=O)C1CC(CCC)CN1C)C(C)Cl

PF-04929113 (SNX-5422)

Information
PF-04929113 (SNX-5422) is a potent and selective HSP90 inhibitor with Kd of 41 nM and induces Her-2 degradation with IC50 of 37 nM. Phase 1/2.
Target
HSP (e.g. HSP90)
Pathway
Cytoskeletal Signaling
Formula
C25H30F3N5O4
CAS Number
908115-27-5
SMILES
CC1(C)CC2=C(C(=NN2C2=CC=C(C(N)=O)C(N[C@H]3CC[C@@H](CC3)OC(=O)CN)=C2)C(F)(F)F)C(=O)C1 |r,c:6,30,t:4,10,12|

PF-3845

Information
PF-3845 is a potent, selective and irreversible FAAH inhibitor with Ki of 230 nM, showing negligible activity against FAAH2.
Target
FAAH
Pathway
Metabolism
Formula
C24H23F3N4O2
CAS Number
1196109-52-0
SMILES
FC(F)(F)C1=CN=C(OC2=CC(CC3CCN(CC3)C(=O)NC3=CN=CC=C3)=CC=C2)C=C1 |c:25,27,29,31,34,t:4,6,9,23|

PF-00562271

Information
PF-00562271 is the benzenesulfonate salt of PF-562271, which is a potent, ATP-competitive, reversible inhibitor of FAK with IC50 of 1.5 nM, ~10-fold less potent for Pyk2 than FAK and >100-fold selectivity against other protein kinases, except for some CDKs. Phase 1.
Target
FAK
Pathway
Angiogenesis
Formula
C27H26F3N7O6S2
CAS Number
939791-38-5
SMILES
OS(=O)(=O)C1=CC=CC=C1.CN(C1=C(CNC2=C(C=NC(NC3=CC=C4NC(=O)CC4=C3)=N2)C(F)(F)F)C=CC=N1)S(C)(=O)=O |c:6,8,12,18,31,33,40,42,t:4,16,22,24|

PF-2545920

Information
PF-2545920 is a potent and selective <b>PDE10A</b> inhibitor with <b>IC50</b> of 0.37 nM, with >1000-fold selectivity over the PDE.
Target
PDE
Pathway
Metabolism
Formula
C25H20N4O
CAS Number
1292799-56-4
SMILES
CN1C=C(C(=N1)C1=CC=C(OCC2=NC3=CC=CC=C3C=C2)C=C1)C1=CC=NC=C1 |c:2,4,17,19,22,25,30,32,t:7,9,13,15,28|

CP-91149

Information
CP-91149 is a selective glycogen phosphorylase (GP) inhibitor with IC50 of 0.13 μM in the presence of glucose, 5- to 10-fold less potent in the absence of glucose.
Target
Phosphorylase
Pathway
Metabolism
Formula
C21H22ClN3O3
CAS Number
186392-40-5
SMILES
CN(C)C(=O)[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CC2=CC(Cl)=CC=C2N1 |r,c:11,13,24,26,t:9,19,21|

PH-797804

Information
PH-797804 is a novel pyridinone inhibitor of p38α with IC50 of 26 nM; 4-fold more selective versus p38β and does not inhibit JNK2. Phase 2.
Target
p38 MAPK
Pathway
MAPK
Formula
C22H19BrF2N2O3
CAS Number
586379-66-0
SMILES
CNC(=O)C1=CC(N2C(C)=CC(OCC3=CC=C(F)C=C3F)=C(Br)C2=O)=C(C)C=C1 |c:9,19,30,t:4,14,16,22,27|

Dacomitinib (PF299804, PF299)

Information
PF-299804 is a potent, irreversible pan-ErbB inhibitor, mostly to EGFR with IC50 of 6 nM, effective against NSCLCs with EGFR or ERBB2 mutations (resistant to gefitinib) as well as those harboring the EGFR T790M mutation. Phase 2.
Target
EGFR
Pathway
Protein Tyrosine Kinase
Formula
C24H25ClFN5O2
CAS Number
1110813-31-4
SMILES
COC1=C(NC(=O)\C=C\CN2CCCCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1 |c:2,27,29,31,34,t:17,21,24|

PF-04691502

Information
PF-04691502 is an ATP-competitive PI3K(α/β/δ/γ)/mTOR dual inhibitor with Ki of 1.8 nM/2.1 nM/1.6 nM/1.9 nM and 16 nM, little activity against either Vps34, AKT, PDK1, p70S6K, MEK, ERK, p38, or JNK. Phase 2.
Target
Akt,mTOR,PI3K
Pathway
PI3K/Akt/mTOR
Formula
C22H27N5O4
CAS Number
1013101-36-4
SMILES
COC1=CC=C(C=N1)C1=CC2=C(C)N=C(N)N=C2N([C@H]2CC[C@@H](CC2)OCCO)C1=O |r,c:4,6,11,17,t:2,9,14|

PF-5274857

Information
PF-5274857 is a potent and selective Smoothened (Smo) antagonist, inhibits Hedgehog (Hh) signaling with IC50 and Ki of 5.8 nM and 4.6 nM, respectively, and can penetrate the blood–brain barrier.
Target
Hedgehog/Smoothened
Pathway
Stem Cells & Wnt
Formula
C20H25ClN4O3S
CAS Number
1373615-35-0
SMILES
CC1=CC(C)=C(N=C1)C1=CC(=NC=C1Cl)N1CCN(CC1)C(=O)CCS(C)(=O)=O |c:4,6,11,13,t:1,9|

Tofacitinib (CP-690550,Tasocitinib)

Information
Tofacitinib is a novel inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent against JAK2 and JAK1.
Target
JAK
Pathway
JAK/STAT
Formula
C16H20N6O
CAS Number
477600-75-2
SMILES
C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N |r,c:10,12,16,18|

Torcetrapib

Information
Torcetrapib is a CETP inhibitor with IC50 of 37 nM, elevates HDL-C and reduces nonHDL-C in plasma. Phase 3.
Target
CETP
Pathway
Metabolism
Formula
C26H25F9N2O4
CAS Number
262352-17-0
SMILES
CCOC(=O)N1[C@H](CC)C[C@H](N(CC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)C(=O)OC)C2=C1C=CC(=C2)C(F)(F)F |r,c:15,17,32,35,37,t:13|

Clindamycin

Information
Clindamycin inhibits protein synthesis by acting on the 50S ribosomal.
Target
Others
Pathway
Others
Formula
C18H33ClN2O5S
CAS Number
18323-44-9
SMILES
CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H](C(C)Cl)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O |r|

PF-4981517

Information
PF-4981517 is a potent and selective inhibitor of CYP3A4 (P450) with IC50 of 0.03 μM, exhibits >500-fold selectivity over CYP3A5 and CYP3A7.
Target
P450 (e.g. CYP17)
Pathway
Metabolism
Formula
C26H32N8
CAS Number
1390637-82-7
SMILES
CN1N=C(C2=C(N(C)N=C2)C2=CC=C(C)C=C2)C2=C(N=CN=C12)N1CC[C@@H](C1)N1CCCCC1 |r,c:8,16,21,t:2,4,11,13,19,23|

Azithromycin Dihydrate

Information
Azithromycin Dihydrate is an acid stable orally administered macrolide antimicrobial drug, structurally related to erythromycin.
Target
Antifection
Pathway
Others
Formula
C38H76N2O14
CAS Number
117772-70-0
SMILES
O.O.CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)C(C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O |r|

Tofacitinib (CP-690550) Citrate

Information
Tofacitinib citrate (CP-690550 citrate) is a novel inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent against JAK2 and JAK1.
Target
JAK
Pathway
JAK/STAT
Formula
C22H28N6O8
CAS Number
540737-29-9
SMILES
OC(=O)CC(O)(CC(O)=O)C(O)=O.C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N |r,c:22,24,28,30|

Azithromycin

Information
Azithromycin is an antibiotic for inhibition of parasite growth with IC50 of 8.4 μM.
Target
Autophagy
Pathway
Ubiquitin
Formula
C38H72N2O12
CAS Number
83905-01-5
SMILES
[H][C@@]1(C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)O[C@H]1[C@H](C)[C@@H](O[C@@]2([H])O[C@H](C)C[C@@H]([C@H]2O)N(C)C)C(C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@@H]1C |r|